Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cell Medica
Biotech
Cell Medica rebrands as Kuur, raises cash for CAR-NKT trials
Kuur will use the money to fund phase 1 trials of autologous and allogeneic CAR natural killer T cell therapies.
Nick Paul Taylor
Mar 11, 2020 8:15am
Chutes & Ladders—Cell Medica names Kite's European chief as CEO
Aug 3, 2018 9:43am
CAR-T player Cell Medica names Kite’s European chief as CEO
Aug 1, 2018 9:30am
EuroBiotech: More Articles of Note
Sep 21, 2017 10:16am
EuroBiotech Report—Idorsia, Bavarian Nordic, Woodford and more
Jun 22, 2017 9:59am
Cell Medica buys clinical-phase WT1-TCR cell therapy
Jun 20, 2017 8:21am
